Report overview
When the mRNA encoding the antigenic protein is injected into the human body, the antigenic protein can be synthesized in the body, thus causing the human immune response against the pathogen infection, namely the mRNA vaccine.
This report contains market size and forecasts of mRNA Vaccines in Global, including the following market information:
Global mRNA Vaccines Market Size 2024-2030, ($ millions)
The global mRNA Vaccines market is projected to reach US$ million by 2029.
We surveyed the mRNA Vaccines companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global mRNA Vaccines Market, by Type, 2024-2030 ($ millions)
Global mRNA Vaccines Market Segment Percentages, by Type
Being Developed
Preclinical
Clinical I
Clinical II
Global mRNA Vaccines Market, by Application, 2024-2030 ($ millions)
Global mRNA Vaccines Market Segment Percentages, by Application
COVID-19
Cancer
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine
Global mRNA Vaccines Market, By Region and Country, 2024-2030 ($ Millions)
Global mRNA Vaccines Market Segment Percentages, by region and country
United States
Europe
Asia
China
Rest of World
Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
MODERNA
Pfizer
Zydus Cadila
Fosun Pharmaceutical
CureVac
Stemirna
